Rasagiline (Azilect, AGN 1135) is an irreversible inhibitor of monoamine oxidase used as a monotherapy in early Parkinson`s disease or as an adjunct therapy in more advanced cases. It is selective for MAO type B over type A by a factor of fourteen. It was developed by Teva Neuroscience, initially investigated by Prof. Moussa B.H. Youdim and Prof.....